linkedin post 2013-01-28 06:43:21

Uncategorized
CANCER TREATMENTS ARE CHANGING with companion diagnostics matching genetic the makeup of a tumor, which undergoes massive mutations, with the drug of choice, or like VIVIA BIOTECH of Madrid, who incubate the tumor with large arrays of drug combinations and doses, measuring apoptosis (kill) rates, to inform patient treatments, and save the patient from being the medical experiment. http://lnkd.in/6BX5qB View in LinkedIn
Read More

linkedin post 2013-01-28 17:45:28

Uncategorized
MY MENTOR WHEN I WAS YOUNG, SAID "ALWAYS TAKE THE HIGH ROAD". It took some serious battles to understand what this meant. Be respectful, give credit where credit is due, take firm stands when you are being compromised and know you are right, and always try to do the right thing. Always ask: "can I write this as my epitaph and feel good about it?". View in LinkedIn
Read More

linkedin post 2013-01-28 17:40:34

Uncategorized
UNDER-PROMISE AND OVER-DELIVER is sound advice for CEOs. A BlowHard CEO who gives overly optimistic predictions will quickly wear thin on boards and investors alike. Be balanced in predictions and forecasts, disclose concerns and problems, and never try to play the field by telling one thing to one group and another to the next. The world is small, and people talk. Once your credibility is compromised, it is gone forever. View in LinkedIn
Read More

linkedin post 2013-01-28 17:33:22

Uncategorized
OVER-SHOPPING A DEAL CAN KILL IT. When investors smell that a company has been round the circuit twice, their suspicions are raised. Rather than be praised for leaving no stone unturned, the CEO is rejected because nobody wants a reject. Keeping your kimono closed, and being highly selective who you show your plan to, will attract more attention. Investors hate to be locked out of an over-subscribed financing, and this is the most desirable (and hardest to achieve) outcome for a CEO raising capital. View in LinkedIn
Read More

linkedin post 2013-01-28 17:27:08

Uncategorized
BIOPHARMA ENTREPRENEURS MUST NOT FALL IN LOVE WITH THEIR INVENTION, but rather set up a series of Go/NoGo decision points. I have seen too many scientific founders devote themselves blindly to their molecule, become blind to the adverse data, and in rare instances actually hide or lie about the adverse data (I have seen this three times in 25 years). View in LinkedIn
Read More

linkedin post 2013-01-28 17:21:50

Uncategorized
CUSTOMER SURVEYS can be a Go/NoGo decision for your emerging business plan. As this article describes, it is important to do your homework to see if your intended customer would actually use your product. VCs will gain comfort from well-constructed quantitative data from such surveys, which should be short and sweet, or your response rate will be poor. http://lnkd.in/Gpm-zX View in LinkedIn
Read More

linkedin post 2013-01-28 15:51:14

Uncategorized
AUTOLOGOUS NERVE CELL IMPLANTS FOR PARALYSIS have been a long time coming, but here is the first approved trial. Knowledge of making mature cells regrow has advanced considerably in recent decades. This is a different type of stem cell treatment, all using the body's own cells to repair a lesion. http://lnkd.in/ZKdKQ4 View in LinkedIn
Read More

linkedin post 2013-01-29 18:21:42

Uncategorized
SETTING UP FOREIGN OFFICES is almost always invaluable if you plan to do business or raise capital abroad. Most CEOs make the fatal mistake in thinking that this is costly (rent, phone, a secretary at least), heavy ear an tear on key staff (travel back and firth), and complex (wholly owned subsidiaries). None of these common objections are true. Done properly, with the right help, this can be a few hundred dollars a month. Done properly, they will greatly assist your foreign business activities. View in LinkedIn
Read More